CRMD

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 9

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,323

Underlying: Common Stock · 5,677 shares

Expires 2034-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on 03/05/2024. These options are fully vested.

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 8

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,124

Underlying: Common Stock · 4,876 shares

Expires 2033-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on 01/14/2023. These options are fully vested.

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 7

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,210

Underlying: Common Stock · 7,790 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on 02/22/2022. These options are fully vested.

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 6

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2028-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 02/16/2018. These options are fully vested.

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 5

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,473

F1 · price: This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 4

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 3

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-112316 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,473

F1 · price: This transaction was executed in multiple trades at prices ranging from $11.41 to $11.44, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-102764 · ownership.xml · nonDerivative · entry 1

Kaplan Myron · CIK 0001672645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,034

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001213900-25-089216 · ownership.xml · derivative · entry 2

Duncan Gregory Scott · CIK 0001831127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,667

Underlying: Common Stock · 13,333 shares

Expires 2031-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0001213900-25-089216 · ownership.xml · nonDerivative · entry 1

Duncan Gregory Scott · CIK 0001831127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-087374 · ownership.xml · derivative · entry 3

Todisco Joseph · CIK 0001774807 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,667

Underlying: Common Stock · 50,000 shares

Expires 2034-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-087374 · ownership.xml · nonDerivative · entry 2

Todisco Joseph · CIK 0001774807 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 509,496

F1 · price: This transaction was executed in multiple trades at prices ranging from $12.82 to $13.27. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-087374 · ownership.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 559,496

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-088337 · ownership.xml · derivative · entry 3

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2034-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0001213900-25-088337 · ownership.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,250

F1 · price: This transaction was executed in multiple trades at prices ranging from $13.00 to $13.25. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-088337 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-087013 · ownership.xml · derivative · entry 6

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,121 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 4

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,990

F2 · price: This transaction was executed in multiple trades at prices ranging from $12.98 to $13.17. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 3

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-087014 · ownership.xml · derivative · entry 4

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 50,000 shares

Expires 2033-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

SEC source: 0001213900-25-087014 · ownership.xml · nonDerivative · entry 3

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,418

SEC source: 0001213900-25-087014 · ownership.xml · nonDerivative · entry 2

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,818

F1 · price: This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-087014 · ownership.xml · nonDerivative · entry 1

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,418

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-087013 · ownership.xml · derivative · entry 5

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,121

Underlying: Common Stock · 12,876 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,990

F1 · price: This transaction was executed in multiple trades at prices ranging from $13.50 to $13.61. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001213900-25-087013 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-25-084126 · ownership.xml · nonDerivative · entry 1

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,298

F1 · price: These shares represent restricted stock units granted on 08/29/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vested 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-084129 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,414

F1 · price: These shares represent restricted stock units granted on 08/29/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vested 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-084123 · ownership.xml · nonDerivative · entry 1

Blum Susan · CIK 0001792253 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,686

F1 · price: These Restricted Stock Units were granted on 08/29/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

SEC source: 0001213900-25-085280 · ownership.xml · nonDerivative · entry 1

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,418

F1 · balance_after: On September 3, 2025, the Reporting Person filed a Form 4 that omitted the Issuer's withholding of common stock to satisfy the tax liability obligation of the Reporting Person. As reported in this amendment, the Issuer withheld 8,880 shares of common stock to satisfy the tax liability obligation of the Reporting Person.

SEC source: 0001213900-25-085282 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,990

F1 · balance_after: On September 3, 2025, the Reporting Person filed a Form 4 that omitted the Issuer's withholding of common stock to satisfy the tax liability obligation of the Reporting Person. As reported in this amendment, the Issuer withheld 8,424 shares of common stock to satisfy the tax liability obligation of the Reporting Person.

SEC source: 0001213900-25-087371 · ownership.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 509,496

F1 · date: This transaction is being reported late due to an inadvertent administrative error.

SEC source: 0001213900-25-028653 · ownership.xml · derivative · entry 4

Lefkowitz Steven W · CIK 0001313149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These stock options, representing a right to purchase 20,000 shares of Common Stock, were granted on 02/22/2022. These stock options are fully vested.

SEC source: 0001213900-25-028653 · ownership.xml · nonDerivative · entry 1

Lefkowitz Steven W · CIK 0001313149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The Reporting Person acquired stock through the exercise of options granted on 02/22/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.

SEC source: 0001213900-25-027598 · ownership.xml · derivative · entry 2

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,830

Underlying: Common Stock · 59,170 shares

Expires 2032-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

SEC source: 0001213900-25-027598 · ownership.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 530,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.

SEC source: 0001213900-25-005671 · ownership.xml · nonDerivative · entry 1

Kaplan Myron · CIK 0001672645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,034

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

SEC source: 0001213900-25-005672 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,473

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

SEC source: 0001213900-25-005673 · ownership.xml · nonDerivative · entry 1

Stewart Robert A · CIK 0001476493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,000

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

SEC source: 0001213900-25-005675 · ownership.xml · nonDerivative · entry 2

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 471,551

SEC source: 0001213900-25-005675 · ownership.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 495,528

F1 · price: These shares represent restricted stock units granted on 01/17/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-005674 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,250

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

SEC source: 0001213900-25-005669 · ownership.xml · nonDerivative · entry 1

Lefkowitz Steven W · CIK 0001313149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,498

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

SEC source: 0001213900-25-005667 · ownership.xml · nonDerivative · entry 1

Duncan Gregory Scott · CIK 0001831127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

SEC source: 0001213900-25-003535 · ownership.xml · nonDerivative · entry 1

David Matthew T · CIK 0001811612 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,270

SEC source: 0001213900-25-003534 · ownership.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,028

SEC source: 0001213900-25-003533 · ownership.xml · nonDerivative · entry 1

Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,992